Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucinda Freeman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Human Genetics : EJHG|February 9, 2023
Views of healthcare professionals on the inclusion of genes associated with non-syndromic hearing loss in reproductive genetic carrier screeningLucinda Freeman, Martin B Delatycki, Jackie Leach Scully, et al.
Journal of Genetic Counseling|August 3, 2023
Should genes for non-syndromic hearing loss be included in reproductive genetic carrier screening: Views of people with a personal or family experience of deafnessLucinda Freeman, Lisa Bristowe, Edwin P Kirk, et al.
Journal of Allied Health|December 5, 2019
The Development of Clinical Genomics and Genetics Within Healthcare: How Should the Allied Health Professions Respond?James M Elliott, Lucinda Freeman, David M Walton, et al.
European Journal of Human Genetics : EJHG|December 6, 2024
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screeningElisha Swainson, Erin Tutty, Lucinda Freeman, et al.
Pathology|December 5, 2013
Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical settingMarcus Hinchcliffe, Huong Le, Anthony Fimmel, et al.
Prenatal Diagnosis|February 3, 2021
Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic reviewStephanie Best, Janet Long, Tahlia Theodorou, et al.
Midwifery|May 8, 2026
Perspectives of women who receive an increased chance result on non-invasive prenatal testing or combined first trimester screening: a qualitative studyShannon McKinn, Nasrin Javid, Ainsley J Newson, et al.
European Journal of Human Genetics : EJHG|November 26, 2024
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditionsLucinda Freeman, Alison D Archibald, Lisa Dive, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 11, 2022
Clinician views and experiences of non-invasive prenatal genetic screening tests in AustraliaShannon McKinn, Nasrin Javid, Ainsley J Newson, et al.
Journal of Genetic Counseling|December 5, 2017
Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General PopulationGeorgina L Fenton, Amelia K Smit, Lucinda Freeman, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Human Genetics : EJHG|February 9, 2023
Views of healthcare professionals on the inclusion of genes associated with non-syndromic hearing loss in reproductive genetic carrier screeningLucinda Freeman, Martin B Delatycki, Jackie Leach Scully, et al.
Journal of Genetic Counseling|August 3, 2023
Should genes for non-syndromic hearing loss be included in reproductive genetic carrier screening: Views of people with a personal or family experience of deafnessLucinda Freeman, Lisa Bristowe, Edwin P Kirk, et al.
Journal of Allied Health|December 5, 2019
The Development of Clinical Genomics and Genetics Within Healthcare: How Should the Allied Health Professions Respond?James M Elliott, Lucinda Freeman, David M Walton, et al.
European Journal of Human Genetics : EJHG|December 6, 2024
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screeningElisha Swainson, Erin Tutty, Lucinda Freeman, et al.
Pathology|December 5, 2013
Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical settingMarcus Hinchcliffe, Huong Le, Anthony Fimmel, et al.
Prenatal Diagnosis|February 3, 2021
Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic reviewStephanie Best, Janet Long, Tahlia Theodorou, et al.
Midwifery|May 8, 2026
Perspectives of women who receive an increased chance result on non-invasive prenatal testing or combined first trimester screening: a qualitative studyShannon McKinn, Nasrin Javid, Ainsley J Newson, et al.
European Journal of Human Genetics : EJHG|November 26, 2024
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditionsLucinda Freeman, Alison D Archibald, Lisa Dive, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 11, 2022
Clinician views and experiences of non-invasive prenatal genetic screening tests in AustraliaShannon McKinn, Nasrin Javid, Ainsley J Newson, et al.
Journal of Genetic Counseling|December 5, 2017
Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General PopulationGeorgina L Fenton, Amelia K Smit, Lucinda Freeman, et al.
Pageof 3